Many investors are struggling to identify compelling reasons to invest in Pfizer at this juncture, particularly when assessing the company's stock market performance this year.
Our Analysis:
As long as the price is below 39.00, follow the recommendations below: - Time frame: D1
- Recommendation: short position
- Entry point: 35.39
- Take Profit 1: 34.00
- Take Profit 2: 31.00
Alternative scenario:
If the level of 39.00 is broken-out, follow the recommendations below: - Time frame: D1
- Recommendation: long position
- Entry point: 39.00
- Take Profit 1: 40.00
- Take Profit 2: 44.00
|
No comments:
Post a Comment